Skip to main content

All Baptist Health Medical Group (by Year)

Submissions from 2017 2017

Estimation of Eligibility for Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors and Associated Costs Based on the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk): Insights from the Department of Veterans Affairs, Khurram Nasir

A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients, Michael Chuong and Minesh Mehta

Breast Cancer Metastases to the Gastrointestinal Tract Presenting with Anemia and Intra-abdominal Bleed., Idrees Khan

A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas, Minesh Mehta

Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options, Yazmin Odia

Effect of Thyroxin Treatment on Carotid Intima-Media Thickness (CIMT) Reduction in Patients with Subclinical Hypothyroidism (SCH): a Meta-Analysis of Clinical Trials, Muhammad Aziz, Anshul Saxena, Sankalp Das, Adnan Younus, Rehan Malik, Muhammad Latif, Choudhry Humayun, Idrees Khan, Ali Adus, Aisha Rasool, Emir Veledar, and Khurram Nasir

Reirradiation of recurrent node-positive non-small cell lung cancer after previous stereotactic radiotherapy for stage I disease : A multi-institutional treatment recommendation, Minesh Mehta

The Role of Radiation Therapy for Pancreatic Cancer in the Adjuvant and Neoadjuvant Settings, Michael Chuong

Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis, Oluseye Ogunmoroti, Emir Veledar, and Khurram Nasir

Determining the Predictors for Cardiac Etiology on Syncope Patients in the ED, Abraham Alfonso Remigio, Rohit Vinod, Julie Lamoureux, and Andres Soto

Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel Survey, Joseph Salami, Javier Valero-Elizondo, Oluseye Ogunmoroti, Adnan Younus, Emir Veledar, and Khurram Nasir

Robotic assisted lobectomy for locally advanced lung cancer, Mark Dylewski

Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525, Minesh Mehta

Multi-institutional analysis of radiation modality use and postoperative outcomes of neoadjuvant chemoradiation for esophageal cancer, Minesh Mehta and Michael Chuong

Predictors of Radiation Therapy-Related Gastrointestinal Toxicity From Anal Cancer Dose-Painted Intensity Modulated Radiation Therapy: Secondary Analysis of NRG Oncology RTOG 0529, Andre Abitbol

HIV/HCV Co-infection and the risk of Cardiovascular Disease: A Meta-analysis, Oluseye Ogunmoroti and Khurram Nasir

Advance Care Planning: A Window to Palliative Care, Suleyki Medina

Living Longer in Good Cardiovascular Health: Prevention and Wellness Makes Economic Cents, Khurram Nasir and Brian Keeley

An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825, Minesh Mehta

Prevalence of Positive Troponin and Echocardiogram Findings and Association With Mortality in Acute Ischemic Stroke, Felipe De Los Rios La Rosa

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria, Minesh Mehta

Concurrent diagnosis of glioblastoma (GBM), neuromyelitis optica (NMO) spectrum disorder and Progressive Multifocal Leukoencephalopathy (PML): imaging, pathology, and clinical course. (P5.161), Yazmin Odia

Association Between Coronary Artery Disease and MicroRNA: Literature Review and Clinical Perspective, Raja Mushtaque, Usman Siddiqui, Adnan Younus, Muhammad Aziz, Choudhry Humayun, Kanaan Mansoor, Idrees Khan, Daniel Del Campo, Ali Adus, and Swetha Gannarapu

BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors, Ashley Roque and Yazmin Odia

Integrative Oncology: A Paradigm Shift, Yoon-Hang "John" Kim